Form 8-K - Current report:
SEC Accession No. 0001193125-25-105148
Filing Date
2025-04-30
Accepted
2025-04-29 21:16:27
Documents
22
Period of Report
2025-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d803323d8k.htm   iXBRL 8-K 40106
2 EX-4.1 d803323dex41.htm EX-4.1 90073
3 EX-5.1 d803323dex51.htm EX-5.1 30588
4 EX-5.2 d803323dex52.htm EX-5.2 14475
5 EX-10.1 d803323dex101.htm EX-10.1 179700
6 EX-99.1 d803323dex991.htm EX-99.1 11690
10 GRAPHIC g803323dsp1.jpg GRAPHIC 7892
11 GRAPHIC g803323g0429140454170.jpg GRAPHIC 1649
12 GRAPHIC g803323g0429141307531.jpg GRAPHIC 3530
13 GRAPHIC g803323g0429141721096.jpg GRAPHIC 5663
  Complete submission text file 0001193125-25-105148.txt   615842

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA itrm-20250428.xsd EX-101.SCH 2511
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20250428_lab.xml EX-101.LAB 18539
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20250428_pre.xml EX-101.PRE 11627
25 EXTRACTED XBRL INSTANCE DOCUMENT d803323d8k_htm.xml XML 3821
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 25890514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)